Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT04338386

Detection and Pathogenesis of Novel Protein F

Status
Not Yet Recruiting
Phase
Study type
Observational
Enrollment
100 (estimated)
Sponsor
Wuhan Asia Heart Hospital · Academic / Other
Sex
All
Age
18 Years – 100 Years
Healthy volunteers
Not accepted

Summary

From December 6, 2019 to March 23, 2020, the research group of Qingkun Fan found a novel protein(temporarily named protein F) in heparin anticoagulant plasma of three patients with heart disease. One patient was diagnosed with multiple myeloma.However, protein F cannot be detected by serum protein electrophoresis. Preliminary studies have shown that this novel protein F have an obvious absorption peak at about 600nm. Placed at 2-8 degrees for 7 days, protein F will be isolated from heparin plasma. To the naked eye, protein F appear to be transparent jelly between the red blood cells and the plasma. The specific protein F, how it is produced, how it causes disease are still unknown. This study will explore how to detect protein F and how it is produced.

Detailed description

Protein F screening was performed on anticoagulant blood plasma with heparin Lithium or blood serum by in-house turbidimetric method in Automatic biochemical analyzer. All patients were followed-up for 3 years by telephones, routine appointment out-patient clinic or returning visit.

Conditions

Timeline

Start date
2020-04-15
Primary completion
2025-03-14
Completion
2028-03-14
First posted
2020-04-08
Last updated
2020-04-10

Source: ClinicalTrials.gov record NCT04338386. Inclusion in this directory is not an endorsement.

Detection and Pathogenesis of Novel Protein F (NCT04338386) · Clinical Trials Directory